Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida

American Journal of Medical Genetics

Volumn 108, Issue 1, 2002, Pages 1-6

  Shaw, Gary M ^a,d   Lammer, Edward J ^b   Zhu, Huiping ^c,d   Baker, Mei Wang ^c   Neri, Eric ^a   Finnell, Richard H ^c,e  

^a March of Dimes Birth Defects Foundation   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e NONE   (United States)

Author keywords

Birth defects; Case control study; Folic acid; Gene environment interaction; Neural tube defects

Indexed keywords

FOLIC ACID; REDUCED FOLATE CARRIER;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SPINA BIFIDA; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

AMINO ACID SUBSTITUTION; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; SPINAL DYSRAPHISM;

EID: 0037083014     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.10195     Document Type: Article

References (36)

1. Potocytosis: Sequestration and transport of small molecules by caveolae
2. Lack of association between mutations in the folate receptor-α gene and spina bifida
3. The role of folate transport and metabolism in neural tube defect risk
4. A data-based approach to diet questionnaire design and testing
5. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review
6. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line
7. A polymorphism (80G → A) in the reduced folate carrier gene and its association with folate status and homocysteinemia
8. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
9. Folic acid receptor alpha microconversion events: A new risk for neural tube defects?
10. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells
11. Neural tube and craniofacial defects with special emphasis on folate pathway genes
12. Transport energetics of the folic acid analogue, methotrexate, in L1210 leukemia cells: Enhanced accumulation by metabolic inhibitors
13. The characteristics of the membrane transport of amethopterin and the naturally occurring folate
14. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell
15. Topology of the Glut 1 glucose transporter deduced from glycosylation scanning mutagenesis
16. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
17. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles
18. The folate receptor works in tandem with a probenicid-sensitive carrier in MA104 cells in vitro
19. Methylenetetrahydrofolate reductase mutation and neural tube defects
20. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies
21. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
22. 5,10-Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects
23. Mice lacking the folicacid binding protein Folbp1 are defective in early embryonic development
24. Is mutated MTHFR a risk factor for neural tube defects?
25. Structural and functional analysis of the human KB cell folate receptor gen promoter: Cooperation of three clustered Sp1-binding sites with initiator re for basal promoter activity
26. The transmembrane pH gradient drives uphill folate transport in rabbit jejunum
27. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California
28. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally
29. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring
30. Maternal vitamin use, genetic variations of infant methylenetetrahydrofolate reductase and risk for spina bifida
31. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
32. Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population
33. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
34. Decreased methylenetetrahydrofolate reductase activity due to the 677C-T mutation in families with spina bifida offspring
35. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb